Ameliorative effects and mechanism of crocetin in arsenic trioxide-induced cardiotoxicity in rats

Arsenic trioxide (ATO) is commonly used to treat patients with acute promyelocytic leukemia since it was authorized by the U.S. Food and Drug Administration in the 1970s, but its applicability has been limited by its cardiotoxic effects. Therefore, the aim of the present study was to investigate the...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Mol Med Rep
Egile Nagusiak: Zhao, Zhifeng, Li, Jinghan, Zheng, Bin, Liang, Yingran, Shi, Jing, Zhang, Jianping, Han, Xue, Chu, Li, Chu, Xi, Gao, Yonggang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: D.A. Spandidos 2020
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7646993/
https://ncbi.nlm.nih.gov/pubmed/33173984
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2020.11587
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak